- Home
- FENC vs RILY Comparison
FENC vs RILY Comparison
Compare FENC & RILY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FENC
- RILY
- Stock Information
- Founded
- FENC 1996
- RILY 1973
- Country
- FENC United States
- RILY United States
- Employees
- FENC N/A
- RILY N/A
- Industry
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- RILY Investment Managers
- Sector
- FENC Health Care
- RILY Finance
- Exchange
- FENC Nasdaq
- RILY Nasdaq
- Market Cap
- FENC 156.9M
- RILY 142.1M
- IPO Year
- FENC 2001
- RILY 2007
- Fundamental
- Price
- FENC $6.49
- RILY $4.20
- Analyst Decision
- FENC Strong Buy
- RILY
- Analyst Count
- FENC 2
- RILY 0
- Target Price
- FENC $14.00
- RILY N/A
- AVG Volume (30 Days)
- FENC 55.8K
- RILY 4.5M
- Earning Date
- FENC 03-10-2025
- RILY 03-17-2025
- Dividend Yield
- FENC N/A
- RILY 11.53%
- EPS Growth
- FENC N/A
- RILY N/A
- EPS
- FENC N/A
- RILY N/A
- Revenue
- FENC $47,538,000.00
- RILY $854,383,000.00
- Revenue This Year
- FENC $28.99
- RILY N/A
- Revenue Next Year
- FENC $63.21
- RILY N/A
- P/E Ratio
- FENC N/A
- RILY N/A
- Revenue Growth
- FENC 123.69
- RILY N/A
- 52 Week Low
- FENC $3.96
- RILY $2.73
- 52 Week High
- FENC $11.49
- RILY $40.09
- Technical
- Relative Strength Index (RSI)
- FENC 47.98
- RILY 44.78
- Support Level
- FENC $5.75
- RILY $4.17
- Resistance Level
- FENC $7.06
- RILY $5.82
- Average True Range (ATR)
- FENC 0.33
- RILY 0.97
- MACD
- FENC -0.07
- RILY -0.10
- Stochastic Oscillator
- FENC 57.25
- RILY 20.46
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
About RILY B. Riley Financial Inc.
B. Riley Financial Inc is a diversified financial services company. The company through its subsidiaries offers investment banking and financial services to corporate, institutional, and high-net-worth clients and also asset disposition, valuation and appraisal, and capital advisory services to retail, wholesale, institutional, lenders, capital providers, private equity investors, and professional services firms in United States, Canada, and Europe. It also provides internet access and subscription services. The reportable operating segments of the company include Capital Markets, Wealth Management, Financial Consulting, Auction and Liquidation, Communications segment, and Consumer products segment.